These 4 Stocks are Up Big 🔥

Biotech is leading today's premarket gainers. Get a full report on all 4 top stocks inside [Image](www.elitetrade.club) Good Morning! Hey, guys and gals. It's Chris from Elite Trade Club, here to give you the day's premarket trading news. Today is Tuesday, September 6th. I hope you enjoyed your Labor Day weekend! Without further ado, let's get ready to trade! Markets 📈 The Dow and S&P 500 lost 1.1% to close out last week's final trading session on Friday. The Nasdaq lagged slightly with a 1.3% loss, while the small-cap Russell 2K was flat on the trading session. Today, futures are on the rise in the holiday-shortened trading week's first trading session. S&P 500 contracts are currently showing a 0.7% gain. Sponsored [26% A Year Return. One Type Of Stock. Really?]( Why settle for puny 4% or 5% yields? My portfolio pays out a 26% cash on cash return. It's not magic or wishful thinking. I just buy one type of regular stock. I'll show you exactly where to find the safest companies that pay the highest yields, but only if you click here right now. If I don't have your name on my list in the next 2 hours, I'll assume you don't want to make monster dividends. [Get All the Details Now...]( Premarket Highlights 🔎 - Volkswagen plans to list Porsche in what is expected to be one of the biggest IPOs in years. - Ernst & Young firm leaders are expected to approve a plan to split up the privately-held accounting giant. - Bed Bath & Beyond's Chief Financial Officer, 52-year-old Gustavo Arnal, jumped to his death from a New York City high-rise on Friday, just days after the company announced job cuts and store closings in response to slowing sales. . What to Watch Today 👀 Rebound Rally It's going to be a short trading week because of the long weekend, but stocks are already looking up after closing last week on a losing streak. However, it will take more than good vibes to carry US benchmarks into positive territory. This week will tell us a lot about where investor sentiment stands after Jerome Powell's comments on interest rate policy caused a rude awakening for some overly-dovish investors. International 🌍 Asia China's Shanghai Composite rallied 1.4% overnight, while other major markets in the region struggled. Australia's ASX 200 lost 0.4%, and Hong Kong's Hang Seng fell 0.1%. Europe Germany's DAX is showing a 0.9% gain midway through its trading session, and the French CAC 40 is up 0.5%. The Euro Stoxx 600 is also showing a 0.5% gain. Major Earnings 💰 Kingsoft Cloud [KC] ... AM UiPath [PATH] ... PM Gitlab [GTLB] ... PM Guidewire Software [GWRE] ... PM HealthEquity [HQY] ... PM Coupa Software [COUP] ... PM Avid Bioservices [CDMO] ... PM Investcorp Credit Management BDC [ICMB] ... PM Economy 🏗 - S&P U.S. services PMI (final) [Aug] ... 9:45a - ISM services index [Aug] ... 10a Running Hot 🔥 Gainers - Rubius Therapeutics [RUBY] >> +15.6% - Organovo Holdings [ONVO] >> +20.8% - First Wave Bio [FWBI] >> +23.3% Decliners - Allena Pharma [ALNA] >> (25.1%) - Great Panther Mining [GPL] >> (54.7%) - Digital World Acquisition [DWAC] >> (22.4%) Illumina Inc [ILMN] - Last Close: $196.07 Illumina is trending after announcing a major regulatory update. News broke this morning that antitrust regulators at the European Union had blocked the genetics company's planned acquisition of biotech firm Grail. Regulators said the deal would have stifled competition and reduced consumer choice in blood-based early cancer detection tests. The European Commission ruled Illumina's proposed remedies didn't adequately address regulators' concerns regarding the deal. Illumina completed its acquisition last year, before receiving EU approval, and was forced to maintain Grail's independence until a ruling was reached. However, the firm has now been ordered to divest Grail. Illumina says it plans to appeal the ruling. ILMN is one of the top S&P 500 stocks in today's premarket with a 4.0% gain on active volume. My Take: This doesn't read like good news for ILMN, but it could be that investors weren't crazy about the deal in the first place. Regardless, the ongoing saga could give short-term traders many opportunities for catalysts in the coming weeks. Iveric Bio [ISEE] - Last Close: $9.44 Upbeat drug data is lifting shares of Iveric Bio. The micro-cap biopharma stock is running hot after announcing positive top-line data from Zimura Gather2 Phase 3 clinical trials in geographic atrophy. Zimura met its primary endpoint, showing statistical significance in its treatment potential and producing a favorable safety profile. Iveric says it plans to submit a New Drug Application to the US Food & Drug Administration by the end of Q1 2023. ISEE is one of today's hottest stocks with a 47.0% gain on the news. My Take: Iveric's latest clinical update makes a strong case for a potential approval in the future. Share prices have shown strong support around $9.50 per share, and today's breakout puts it past a key resistance point. HyreCar Inc [HYRE] - Last Close: $0.8032 Shares of HyreCar are surging after a major announcement. The web-based carsharing marketplace operator announced this morning that it had secured a pivotal $100 million revolving line of credit from a premier global bank. HyreCar said it has entered into a deal with Medalist Partners and an unnamed bank for a $100 million warehousing line of credit. The bank will provide primary financing, while Medalist will provide $20 million in additional funding. The company said its fleet operator partner, AmeriDrive Holdings, will use the facility to buy vehicles for exclusive listing on the HyreCar platform through a bankruptcy-remote joint venture company. HyreCar expects AmeriDrive to add 6,000 to 7,000 vehicles over the next 12 to 18 months to the platform, with the vehicles serving as collateral under the facility, the company said. HYRE is trading actively with a 32.0% gian on the news. My Take: HYRE could be an interesting speculative trade. The new credit line shows the company has secured some legit institutional backing, so maybe it's ready to break into the big leagues. I'm keeping my eye on this one. Ideanomics [IDEX] - Last Close: $0.607 Ideanomics is climbing after a key earnings release. The commercial EV company released its full-year 2021 financial results after Friday's closing bell, and the numbers are getting a warm reception in today's premarket. Ideanomics reported total revenues of $114 million, marking a sharp improvement from the previous year's $26.8 million figure. However, the company's operating loss widened to (-$0.57) pre diluted share from 2020's (-$0.47) diluted EPS. The company also announced it had entered into a standby equity purchase agreement with YA II PN. IDEX is trading actively with a 7.9% gain on the news. My Take: Ideanomics' strong revenue growth could be the catalyst for this move, but this company still has a long way to go before it becomes an established firm. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](